Richmond Pharmacology is excited to join BioJapan 2026 in Yokohama, Japan, on  07- 09 October 2026.

Connecting global leaders in biotechnology and life sciences, BioJapan is a premier platform for fostering partnerships, sharing cutting-edge research, and driving innovation across the healthcare and pharmaceutical sectors.

Representing Richmond Pharmacology

  • Dr Jörg Taubel, Chief Executive Officer
  • Stephen Wilkinson, Business Development Manager
  • Nobuo Ittetsu, Head of Japanese Volunteer Recruitment
  • Minoru Takada, Japanese Business Development Executive

We look forward to connecting with attendees to discuss Richmond’s expertise in:

  • Innovations in biotechnology and clinical trial design
  • Regulatory pathways for emerging therapies
  • Patient-centric approaches and recruitment strategies
  • Collaboration between academia, industry, and regulators
  • Data-driven solutions for accelerating development

Connect With Us

If you are attending BioJapan 2026 and would like to explore partnership or development opportunities email us at: 📧 fasteranswers@richmondpharmacology.com

‍

Latest news

Leadership Spotlight - Head of Pharmacovigilance

November 16, 2026
Amina Ghareeb on Building Richmond's Pharmacovigilance Expertise
Read more

Upcoming Event

JSCPT 2026

27 - 28 November 2026
Richmond Pharmacology is excited to join the JSCPT Annual Meeting 2026 in Tokyo, Japan, on 27-28 November 2026.
View event